...
search icon
vtvt-img

vTv Therapeutics Inc Share Price

VTVT
NAQ
$36.49
+$2.1
(6.11%)
1D
Industry: Biotechnology Sector: Health Care

vTv Therapeutics Inc Analyst Forecast

vTv Therapeutics Inc Share Price Chart

vTv Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$135.43M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
30.41K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.46
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$14 L
$44 H
$36.49

About vTv Therapeutics Inc, Common Stock

vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. more

Industry: BiotechnologySector: Health Care

vTv Therapeutics Inc Stock Returns

Time FrameVTVTSectorS&P500
1-Week Return17.67%0.91%2.13%
1-Month Return6.95%-0.72%-0.47%
3-Month Return17.71%2.24%1.29%
6-Month Return151.83%19.1%7.71%
1-Year Return102.72%7.15%14.7%
3-Year Return5.34%16.96%67.75%
5-Year Return-66.21%33.23%76.25%
10-Year Return-85.05%142.74%271.83%

vTv Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue6.41M4.00M2.02M9.00K1.02M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":62.44,"profit":true},{"date":"2022-12-31","value":31.46,"profit":true},{"date":"2023-12-31","value":0.14,"profit":true},{"date":"2024-12-31","value":15.86,"profit":true}]
Cost of Revenue11.02M89.00K92.00K90.00K89.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":0.81,"profit":true},{"date":"2022-12-31","value":0.84,"profit":true},{"date":"2023-12-31","value":0.82,"profit":true},{"date":"2024-12-31","value":0.81,"profit":true}]
Gross Profit(4.60M)4.00M2.02M(90.00K)1.02M[{"date":"2020-12-31","value":-114.88,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.39,"profit":true},{"date":"2023-12-31","value":-2.25,"profit":false},{"date":"2024-12-31","value":25.39,"profit":true}]
Gross Margin(71.73%)100.00%100.00%(1000.00%)100.00%[{"date":"2020-12-31","value":-71.73,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1000,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses7.25M25.67M24.56M25.50M25.20M[{"date":"2020-12-31","value":28.25,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.68,"profit":true},{"date":"2023-12-31","value":99.36,"profit":true},{"date":"2024-12-31","value":98.17,"profit":true}]
Operating Income(11.85M)(21.66M)(22.54M)(25.50M)(24.18M)[{"date":"2020-12-31","value":-1185200000,"profit":false},{"date":"2021-12-31","value":-2166200000,"profit":false},{"date":"2022-12-31","value":-2254000000,"profit":false},{"date":"2023-12-31","value":-2550200000,"profit":false},{"date":"2024-12-31","value":-2418000000,"profit":false}]
Total Non-Operating Income/Expense(1.63M)4.04M(2.00M)60.00K3.14M[{"date":"2020-12-31","value":-40.4,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-49.47,"profit":false},{"date":"2023-12-31","value":1.49,"profit":true},{"date":"2024-12-31","value":77.82,"profit":true}]
Pre-Tax Income(12.80M)(17.62M)(24.87M)(25.97M)(22.61M)[{"date":"2020-12-31","value":-1280200000,"profit":false},{"date":"2021-12-31","value":-1761600000,"profit":false},{"date":"2022-12-31","value":-2487300000,"profit":false},{"date":"2023-12-31","value":-2596600000,"profit":false},{"date":"2024-12-31","value":-2260500000,"profit":false}]
Income Taxes(3.98M)115.00K200.00K(5.72M)100.00K[{"date":"2020-12-31","value":-1987.5,"profit":false},{"date":"2021-12-31","value":57.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2858,"profit":false},{"date":"2024-12-31","value":50,"profit":true}]
Income After Taxes(8.83M)(17.73M)(25.07M)(20.25M)(22.70M)[{"date":"2020-12-31","value":-882700000,"profit":false},{"date":"2021-12-31","value":-1773100000,"profit":false},{"date":"2022-12-31","value":-2507300000,"profit":false},{"date":"2023-12-31","value":-2025000000,"profit":false},{"date":"2024-12-31","value":-2270500000,"profit":false}]
Income From Continuous Operations(12.80M)(17.73M)(25.07M)(27.61M)(22.70M)[{"date":"2020-12-31","value":-1280200000,"profit":false},{"date":"2021-12-31","value":-1773100000,"profit":false},{"date":"2022-12-31","value":-2507300000,"profit":false},{"date":"2023-12-31","value":-2761500000,"profit":false},{"date":"2024-12-31","value":-2270500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(8.50M)(12.99M)(19.16M)(20.25M)(18.46M)[{"date":"2020-12-31","value":-849900000,"profit":false},{"date":"2021-12-31","value":-1298700000,"profit":false},{"date":"2022-12-31","value":-1916400000,"profit":false},{"date":"2023-12-31","value":-2025000000,"profit":false},{"date":"2024-12-31","value":-1846200000,"profit":false}]
EPS (Diluted)(0.19)(0.22)(0.25)(5.00)(3.41)[{"date":"2020-12-31","value":-19,"profit":false},{"date":"2021-12-31","value":-22,"profit":false},{"date":"2022-12-31","value":-25,"profit":false},{"date":"2023-12-31","value":-500,"profit":false},{"date":"2024-12-31","value":-341.22,"profit":false}]

vTv Therapeutics Inc Ratios

vTv Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

VTVT
Cash Ratio 9.69
Current Ratio 9.79

vTv Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VTVT
ROA (LTM) -26.13%
ROE (LTM) -64.17%

vTv Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VTVT
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

vTv Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VTVT
Trailing PE NM
Forward PE NM
P/S (TTM) 7966.38
P/B 1.92
Price/FCF NM
EV/R 2193.20
EV/Ebitda NM
PEG NM

FAQs

What is vTv Therapeutics Inc share price today?

vTv Therapeutics Inc (VTVT) share price today is $36.49

Can Indians buy vTv Therapeutics Inc shares?

Yes, Indians can buy shares of vTv Therapeutics Inc (VTVT) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VTVT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of vTv Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of vTv Therapeutics Inc (VTVT) via the Vested app. You can start investing in vTv Therapeutics Inc (VTVT) with a minimum investment of $1.

How to invest in vTv Therapeutics Inc shares from India?

You can invest in shares of vTv Therapeutics Inc (VTVT) via Vested in three simple steps:

  • Click on Sign Up or Invest in VTVT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in vTv Therapeutics Inc shares
What is vTv Therapeutics Inc 52-week high and low stock price?

The 52-week high price of vTv Therapeutics Inc (VTVT) is $44. The 52-week low price of vTv Therapeutics Inc (VTVT) is $14.

What is vTv Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of vTv Therapeutics Inc (VTVT) is

What is vTv Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of vTv Therapeutics Inc (VTVT) is 1.92

What is vTv Therapeutics Inc dividend yield?

The dividend yield of vTv Therapeutics Inc (VTVT) is 0.00%

What is the Market Cap of vTv Therapeutics Inc?

The market capitalization of vTv Therapeutics Inc (VTVT) is $135.43M

What is vTv Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of vTv Therapeutics Inc is VTVT

How Can Investors Use vTv Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of vTv Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether vTv Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from vTv Therapeutics Inc shares for Indian investors?

When investing in vTv Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the vTv Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare vTv Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of vTv Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that vTv Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top